Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-024665
Filing Date
2015-03-31
Accepted
2015-03-31 15:58:38
Documents
1
Period of Report
2015-03-27

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5191
  Complete submission text file 0001104659-15-024665.txt   6516
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Issuer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address T2 BIOSYSTEMS, INC. 101 HARTWELL AVE LEXINGTON MA 02421
Business Address
McDonough John (Reporting) CIK: 0001615937 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36571 | Film No.: 15739086